Althea Danmark Aps

Ledelsesberetning

The Company's principal activities
The Company's principal activities consist in consultancy regarding information technology. The purpose is to operate trade and industri as well as all business related thereto.
Development in activities and the financial situation
The Company's Income Statement of the financial year 1 January 2024 - 31 December 2024 shows a result of DKK -117.839 and the Balance Sheet at 31 December 2024 a balance sheet total of DKK 62.916 and an equity of DKK -1.708.248.
Restoration of share capital
On 22 June 2023 It has been decided that the Company will enter voluntary liquidation.
Capital resources
The company has a negative equity.
In order to secure that the company's capital resources are sound at any time and that sufficient liquidity is available to meet the Company's current and future liabilities as they fall due, the parent company has issued a letter of support.
The parent company F2i Medtech S.P.A, a company registered in Italy with registration no. MI-2121062, declares to provide sufficient business and financial support to finance current plans and budgets for Althea Danmark ApS under liquidation for a minimum of 12 months from the balance date at 31 December 2024, up to the amount of DKK 1.800.000.
This commitment has been provided to the executive board of Althea Danmark ApS under liquidation in order to ensure Althea Danmark ApS under liquidation can meet its obligations as they all due. This commitment terminates at December 31 2025.
This letter of financial support is irrevocable and enforced by the executive board of Althea Danmark ApS under liquidation without any terms or conditions.
Expectations for the future
The company will not continue the operations in 2025.

Beskrivelse af virksomhedens væsentligste aktiviteter

The Company's principal activities
The Company's principal activities consist in consultancy regarding information technology. The purpose is to operate trade and industri as well as all business related thereto.

Beskrivelse af udviklingen i virksomhedens aktiviteter og økonomiske forhold

Development in activities and the financial situation
The Company's Income Statement of the financial year 1 January 2024 - 31 December 2024 shows a result of DKK -117.839 and the Balance Sheet at 31 December 2024 a balance sheet total of DKK 62.916 and an equity of DKK -1.708.248.
Restoration of share capital
On 22 June 2023 It has been decided that the Company will enter voluntary liquidation.
Capital resources
The company has a negative equity.
In order to secure that the company's capital resources are sound at any time and that sufficient liquidity is available to meet the Company's current and future liabilities as they fall due, the parent company has issued a letter of support.
The parent company F2i Medtech S.P.A, a company registered in Italy with registration no. MI-2121062, declares to provide sufficient business and financial support to finance current plans and budgets for Althea Danmark ApS under liquidation for a minimum of 12 months from the balance date at 31 December 2024, up to the amount of DKK 1.800.000.
This commitment has been provided to the executive board of Althea Danmark ApS under liquidation in order to ensure Althea Danmark ApS under liquidation can meet its obligations as they all due. This commitment terminates at December 31 2025.
This letter of financial support is irrevocable and enforced by the executive board of Althea Danmark ApS under liquidation without any terms or conditions.

Beskrivelse af virksomhedens forventede udvikling

Expectations for the future
The company will not continue the operations in 2025.